Nordea Investment Management Ab Acadia Pharmaceuticals Inc Transaction History

Nordea Investment Management Ab

$103 Billion
Q2 2025

A detailed history of Nordea Investment Management Ab transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nordea Investment Management Ab holds 277,700 shares of ACAD stock, worth $6.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

277,700

Previous 275,067 0.96%

Holding current value

$6.61 Million

Previous $4.57 Million 31.11%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$14.1 - $22.95 $37,125 - $60,427	2,633 Added 0.96%	277,700 $5.99 Million
Q1 2025 May 14, 2025	BUY	$16.61 - $20.29 $183,307 - $223,920	11,036 Added 4.18%	275,067 $4.57 Million
Q4 2024 Jan 06, 2025	BUY	$14.29 - $18.76 $50,243 - $65,960	3,516 Added 1.35%	264,031 $4.84 Million
Q3 2024 Nov 05, 2024	SELL	$15.14 - $19.14 $226,645 - $286,525	-14,970 Reduced 5.43%	260,515 $4.01 Million
Q2 2024 Aug 08, 2024	SELL	$14.62 - $18.42 $687,417 - $866,089	-47,019 Reduced 14.58%	275,485 $4.48 Million
Q1 2024 May 02, 2024	SELL	$17.79 - $30.86 $4.69 Million - $8.13 Million	-263,498 Reduced 44.97%	322,504 $5.96 Million
Q4 2023 Jan 10, 2024	SELL	$20.78 - $31.77 $257,692 - $393,979	-12,401 Reduced 2.07%	586,002 $18.3 Million
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $3,647 - $5,857	-175 Reduced 0.03%	598,403 $12.5 Million
Q2 2023 Jul 07, 2023	BUY	$17.8 - $25.65 $307,299 - $442,821	17,264 Added 2.97%	598,578 $14.3 Million
Q1 2023 Apr 19, 2023	SELL	$16.32 - $20.92 $541,383 - $693,979	-33,173 Reduced 5.4%	581,314 $10.9 Million
Q4 2022 Feb 08, 2023	SELL	$14.2 - $18.63 $157,293 - $206,364	-11,077 Reduced 1.77%	614,487 $9.78 Million
Q3 2022 Oct 19, 2022	SELL	$14.11 - $18.27 $63,720 - $82,507	-4,516 Reduced 0.72%	625,564 $10.2 Million
Q2 2022 Aug 09, 2022	BUY	$13.01 - $27.22 $137,320 - $287,307	10,555 Added 1.7%	630,080 $8.89 Million
Q1 2022 Apr 11, 2022	BUY	$20.94 - $27.5 $183,560 - $241,065	8,766 Added 1.44%	619,525 $15 Million
Q4 2021 Jan 20, 2022	SELL	$16.79 - $27.09 $81,800 - $131,982	-4,872 Reduced 0.79%	610,759 $14.2 Million
Q3 2021 Nov 01, 2021	BUY	$15.78 - $24.77 $12.2 Million - $19.1 Million	771,450 Added 167.78%	1,231,262 $0
Q3 2021 Nov 01, 2021	SELL	$15.78 - $24.77 $9.71 Million - $15.2 Million	-615,631 Reduced 50.0%	615,631 $10.3 Million
Q2 2021 Jul 16, 2021	BUY	$19.4 - $27.42 $8.63 Million - $12.2 Million	444,722 Added 2947.13%	459,812 $11.2 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $377,551 - $829,799	15,090 New	15,090 $400,000
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $23,320 - $28,120	-1,000 Closed	0 $0
Q4 2018 Feb 19, 2019	BUY	$14.32 - $22.92 $14,320 - $22,920	1,000 New	1,000 $16,000

Others Institutions Holding ACAD

# of Institutions

352

Shares Held

163M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.85B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Acadia Pharmaceuticals Inc Transaction History